Volume : 11, Issue : 05, May – 2024
Title:
ANTI-CONVULSANT AND ANXIOLYTIC ACTIVITY OF SOME MEDICINAL PLANTS: REVIEW
Authors :
Mr. Om Ajay Kate, Mr. Atharv Sunil Zadap, Mr. Ashok Rugharam Godara, Mr. Nishant Bhagwan Chinchore
Abstract :
Anticonvulsants (also known as antiepileptic drugs, antiseizure drugs, or anti-seizure medications (ASM)) are a diverse group of pharmacological agents used in the treatment of epileptic seizures. Anticonvulsants are also increasingly being used in the treatment of bipolar disorder and borderline personality disorder, since many seem to act as mood stabilizers, and for the treatment of neuropathic pain. Anticonvulsants suppress the excessive rapid firing of neurons during seizures. Anticonvulsants also prevent the spread of the seizure within the brain. Conventional antiepileptic drugs may block sodium channels or enhance γ-aminobutyric acid (GABA) function. Several antiepileptic drugs have multiple or uncertain mechanisms of action. Next to the voltage-gated sodium channels and components of the GABA system, their targets include GABAA receptors, the GABA transporter type 1, and GABA transaminase. Additional targets include voltage-gated calcium channels, SV2A, and α2δ. By blocking sodium or calcium channels, antiepileptic drugs reduce the release of excitatory glutamate, whose release is considered to be elevated in epilepsy, but also that of GABA. This is probably a side effect or even the actual mechanism of action for some antiepileptic drugs, since GABA can itself, directly or indirectly, act proconvulsively. Another potential target of antiepileptic drugs is the peroxisome proliferator-activated receptor alpha.
A drug used to treat symptoms of anxiety, such as feelings of fear, dread, uneasiness, and muscle tightness that may occur as a reaction to stress. Most anxiolytics block the action of certain chemicals in the nervous system. Also called antianxiety agent and anxiolytic agent.
Keywords: Epilepsy, gamma-aminobutyric acid, Trauma, Anxiolytic, Lavandula angustifolia, Ferulic acid.
Cite This Article:
Please cite this article in press Om Ajay Kate et al, Anti-Convulsant And Anxiolytic Activity Of Some Medicinal Plants: Review.,Indo Am. J. P. Sci, 2024; 11 (5).
Number of Downloads : 10
References:
1. Bulloch AG, Currie S, Guyn L, et al. Estimates of the treated prevalence of bipolar disorders by mental health services in the general population: comparison of results from administrative and health survey data. Chronic Dis Inj Can. 2011;31(3):129–34.
2. Roberson-Nay R, Kendler KS. Panic disorder and its subtypes: a comprehensive analysis of panic symptom heterogeneity using epidemiological and treatment seeking samples. Psychol Med. 2011:1–11.
3. Culpepper L. Generalized anxiety disorder and medical illness. J Clin Psychiatry. 2009;70(Suppl 2):20–24.
4. Goodwin RD, Davidson KW, Keyes K. Mental disorders and cardiovascular disease among adults in the United States. J Psychiatr Res. 2009;43(3):239–46.
5. Gureje O. Comorbidity of pain and anxiety disorders. Curr Psychiatry Rep. 2008;10(4):318–22
6. Ringbäck Weitoft G, Rosén M. Is perceived nervousness and anxiety a predictor of premature mortality and severe morbidity? A longitudinal follow up of the Swedish survey of living conditions. J Epidemiol Community Health. 2005;59(9):794–98.
7. Weisberg RB. Overview of generalized anxiety disorder: epidemiology, presentation, and course. J Clin Psychiatry. 2009;70(Suppl 2):4–9.
8. Chauvel P, McGonigal A. Emergence of semiology in epileptic seizures. Epilepsy & Behavior.2014; 38:94–103. Available: https:// doi. org/ https: //doi.org/ 10.1016/j. yebeh. 2013 .12.003
9. Owolabi LF, Owolabi SD, Taura AA, Alhaji ID, Ogunniyi A. Prevalence and burden of epilepsy in Nigeria: A systematic review and meta-analysis of community-based door-to-door surveys. Epilepsy & Behavior. 2019; 92:226–234. Available:https://doi.org/https://doi.org/10.1016/j.yebeh.2018.12.017
10. Sinke MRT, Braun KPJ, Otte WM. White matter abnormalities at a regional and voxel level in focal and generalized epilepsy: A systematic review and meta-analysis. NeuroImage: Clinical. 2016; 12:902–909. Available :https://doi.org/ https: //doi.org/10.1016/j.nicl.2016.10.025
11. Jiruska P, Csicsvari J, Powell AD, Fox JE, Chang WC, Vreugdenhil M, Li X, Palus M, Bujan AF, Dearden RW, Jefferys JGR. High-frequency network activity, global increase in neuronal activity, and synchrony expansion precede epileptic seizures in vitro. Journal of Neuroscience.2010;30(16):5690–5701. Available:https://doi.org/10.1523/JNEUROSCI.0535-10.2010
12. Nawafleh S, Qaswal AB, Suleiman A, Alali O, Zayed FM, Al-Adwan MA, Bani Ali M. GABA receptors can depolarize the neuronal membrane potential via quantum tunneling of chloride ions: a quantum mathematical study. In Cells. 2022;11(7). Available: https://doi.org /10.3390/cells11071145
13. Greenfield LJ. Molecular mechanisms of antiseizure drug activity at GABAA receptors. Seizure.2013; 22(8):589–600. Available: https: // doi.org https:// doi.org/10.1016 /j.seizure. 2013 .04.015
14. Janković SM, Dješević M, Janković SV. Experimental GABA A receptor agonists and allosteric modulators for the treatment of focal epilepsy. Journal of Experimental Pharmacology. 2021;13: 235–244.Available:https://doi.org/10.2147/JEP.S242964
15. Akyuz E, Polat AK, Eroglu E, Kullu I, Angelopoulou E, Paudel YN. Revisiting the role of neurotransmitters in epilepsy: An updated review. Life Sciences. 2021;265: 118826. Available:https://doi.org/https://doi.org/10.1016/j.lfs.2020.118826
16. Alten B, Guzikowski NJ, Zurawski Z, Hamm HE, Kavalla ET. Presynaptic mechanisms underlyingGABAB-receptor-mediated inhibition of spontaneous neurotransmitter release. Cell Reports.2022;38(3):110255.Available:https://doi.org/https://doi.org/10.1016/j.celrep.2021.110255
17. Srivastava I, Vazquez-Juarez E,Lindskog M. Reducing glutamate uptake in rat hippocampal slices enhances astrocytic membrane depolarization while down-regulating CA3–CA1 synaptic response. Frontiers in Synaptic Neuroscience.2020; 12:1–11. Available: https:// doi.org /10.3389/fnsyn.2020.00037
18. Sen A, Jette N, Husain M, Sander JW. Epilepsy in older people. The Lancet. 2020; 395(10225): 735–748. Available: https://doi.org/ https:// doi. org/ 10.1016/S0140-6736(19)33064-8
19. Olubunmi A. Epilepsy in Nigeria – A review of etiology, epidemiology and management. Benin Journal of Postgraduate Medicine. 2009;8(1). Available:https://doi.org/10.4314/bjpm.v8i1.47362
20. Laxer KD, Trinka E, Hirsch LJ, Cendes F, Langfitt J, Delanty N, Resnick T, Benbadis SR. The consequences of refractory epilepsy and its treatment. Epilepsy & Behavior. 2014; 37:59–70. Available:https://doi.org/https://doi.org/10.1016/j.yebeh.2014.05.031
21. Siewe Fodjo JN, Remme JHF, Preux PM, Colebunders R. Meta-analysis of epilepsy prevalence in West Africa and its relationship with onchocerciasis endemicity and control. International Health. 2020;12(3):192–202. Available:https://doi.org/10.1093/inthealth/ihaa012
22. Kennedy PGE, Rodgers J. Clinical and neuropathogenetic aspects of human African trypanosomiasis. Frontiers in Immunology. 2019; 10:1–11. Available: https://doi.org/ 10. 33 89/fimmu.2019.00039
23. Recht J, Siqueira AM, Monteiro WM, Herrera SM, Herrera S, Lacerda MVG. Malaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination. Malaria Journal. 2017;16(1):273. Available: https://doi.org/10.1186/s12936-017-1925-6
24. Ba-Diop A, Marin B, Druet-Cabanac M, Ngoungou EB, Newton CR, Preux PM. Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa. The Lancet Neurology.2014;13(10):1029–1044. Available:https://doi.org/https://doi.org/10.1016/S1474-4422(14)70114-0
25. Balogun JA, Bankole OB, Okere O, Uche EO, Balogun FM, Shilong DJ, Jimoh AO, Adeolu AA. Epidemiology of brain tumors among adolescents and young adults in Nigeria. Journal of Clinical Neuroscience. 2022; 96:50–55. Available:https://doi.org/https://doi.org/10.1016/j.jocn.2021.12.019
26. Abdel Razek AAK, Alvarez H, Bagg S, Refaat S, Castillo M. Imaging spectrum of CNS vasculitis. Radiographics. 2014;34(4):873–894. Available:https://doi.org/10.1148/rg.344135028
27. Wilson MP, Plecko B, Mills PB, Clayton PT Disorders affecting vitamin B6 metabolism. Journal of Inherited Metabolic Disease. 2019;42(4):629–646. Available:https://doi.org/10.1002/jimd.12060
28. Lesca G, M⊘ller RS, Rudolf G, Hirsch E, Hjalgrim H, Szepetowski P. Update on the genetics of the epilepsy‐aphasia spectrum and role of GRIN2A mutations. Epileptic Disorders. 2019; 21:S41–S47.
29. Engelborghs S, D’hooge R, De Deyn PP. Pathophysiology of epilepsy. Acta Neurologica Belgica. 2000;100(4):201–213.
30. Stouffer MA, Golden JA, Francis F. Neuronal migration disorders: focus on the cytoskeleton and epilepsy. Neurobiology of Disease. 2016; 92:18–45.
31. Verrotti A, Spalice A, Ursitti F, Papetti L, Mariani R, Castronovo A, Mastrangelo M, Iannetti P. New trends in neuronal migration disorders. European Journal of Paediatric Neurology. 2010; 14(1):1–12.
32. Sarnat HB, Flores-Sarnat L. Excitatory/inhibitory synaptic ratios in polymicrogyria and down syndrome help explain epileptogenesis in malformations. Pediatric Neurology. 2021; 116:41–54.
33. Ferland RJ, Batiz LF, Neal J, Lian G, Bundock E, Lu J, Hsiao YC, Diamond R, Mei D, Banham AH. Disruption of neural progenitors along the ventricular and subventricular zones in periventricular heterotopia. Human Molecular Genetics. 2009;18(3):497–516.
34. Sarkisian MR, Bartley CM, Rakic P. Trouble making the first move: interpreting arrested neuronal migration in the cerebral cortex. Trends in Neurosciences. 2008; 31(2):54–61.
35. Leventer RJ, Guerrini R, Dobyns WB. Malformations of cortical development and epilepsy. Dialogues in Clinical Neuroscience; 2022.
36. Meuwissen MEC, Mancini GMS. Neurological findings in incontinentia pigmenti; a review. European Journal of Medical Genetics. 2012; 55(5):323–331.
37. D’Agostino MD, Bernasconi A, Das S, Bastos A, Valerio RM, Palmini A, Costa da Costa J, Scheffer IE, Berkovic S, Guerrini R. Subcortical band heterotopia (SBH) in males: clinical, imaging and genetic findings in comparison with females. Brain. 2002; 125(11):2507–2522.
38. Liu JS. Molecular genetics of neuronal migration disorders. Current Neurology and Neuroscience Reports. 2011; 11(2): 171–178.
39. Wu Q, Liu J, Fang A, Li R, Bai Y, Kriegstein AR, Wang X. The dynamics of neuronal migration. Cellular and Molecular Control of Neuronal Migration. 2014;25–36
40. Silveira V, Santos Rubio KT, PoletiMartucci ME. The anxiolytic effect of Anthemis nobilis L. (roman chamomile) and Citrus reticulata Blanco (tangerine) essential oils using the light-dark test in zebrafish (Danio rerio). J Ethnopharmacol. 2022; 298:115580.
41. Henry BJ. Symptom Management in Oncology: Depression and Anxiety. Semin Oncol Nurs. 2022; 38(1):151251. M.-A. Crocq. A history of anxiety: from Hippocrates to DSM. Dialogues Clin. Neurosci., 17 (2015), pp. 319-325.
42. V. Vu, D. Conant-Norville. Anxiety, vol. 44, Psychiatric Clinics of North America (2021), pp. 373-380.
43. Baxter A.J., T. Vos, K.M. Scott, A.J. Ferrari, H.A. Whiteford. The global burden of anxiety disorders in 2010. Psychol. Med., 44 (2014), pp. 2363-2374.
44. S.M. Hendriks, J. Spijker, C.M.M. Licht, A.T.F. Beekman, F. Hardeveld, R. de Graaf, N.M. Batelaan, B.W.J.H. Penninx. Disability in anxiety disorders. J. Affect. Disord., 166 (2014), pp. 227-233. E. Di Giacomo, F. Colmegna, E. Biagi, L. Zappa, M. Caslini, A. Dakanalis, M. Clerici. Anxiety and depression. J. Nerv. Ment. Dis., 209 (2021), pp. 188-195.